IBERDOMIDE 1.6mg, IBERDOMIDE 1.3mg, IDERDOMIDE 1mg, ixazomib citrate, Dexaméthasone, IDERDOMINE 0.75mg clinical trials

A multi-center open-label phase 2 study of Ixazomib, Iberdomide and dexamethasone in elderly patients with multiple myeloma at first relapse

This study looks at a new combination of medicines (Ixazomib, Iberdomide, and Dexamethasone) for older people with multiple myeloma that has come back. It aims to see how well these drugs work together to control the disease.